VCM
MRNA icon

Versant Capital Management’s Moderna MRNA Stock Holding History

Versant Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Buy
2,189
+1,013
+86% +$52.4K 0.01% 740
2026
Q1 		$59.7K Buy
1,176
+494
+72% +$23K 0.01% 1129
2025
Q4 		$20.1K Buy
682
+434
+175% +$11.8K ﹤0.01% 1631
2025
Q3 		$6.41K Sell
248
-184
-43% -$5.13K ﹤0.01% 2111
2025
Q2 		$11.9K Sell
432
-1,161
-73% -$30.6K ﹤0.01% 1809
2025
Q1 		$45.2K Buy
1,593
+1,280
+409% +$45.4K 0.01% 909
2024
Q4 		$13K Buy
313
+196
+168% +$9.37K ﹤0.01% 1270
2024
Q3 		$7.82K Sell
117
-63
-35% -$5.78K ﹤0.01% 1146
2024
Q2 		$21.4K Buy
180
+129
+253% +$16.3K 0.01% 687
2024
Q1 		$5.43K Buy
51
+10
+24% +$1.01K ﹤0.01% 999
2023
Q4 		$4.08K Buy
41
+3
+8% +$252 ﹤0.01% 1039
2023
Q3 		$3.92K Buy
38
+17
+81% +$1.9K ﹤0.01% 1061
2023
Q2 		$2.55K Sell
21
-1
-5% -$133 ﹤0.01% 1286
2023
Q1 		$3.36K Sell
22
-1
-4% -$165 ﹤0.01% 1092
2022
Q4 		$4.13K Sell
23
-341
-94% -$55.8K ﹤0.01% 946
2022
Q3 		$43K Sell
364
-29
-7% -$4.4K 0.02% 247
2022
Q2 		$56K Buy
393
+28
+8% +$4K 0.02% 204
2022
Q1 		$63K Sell
365
-13
-3% -$2.19K 0.02% 213
2021
Q4 		$96K Sell
378
-9
-2% -$2.63K 0.03% 162
2021
Q3 		$149K Buy
387
+366
+1,743% +$135K 0.05% 120
2021
Q2 		$5K Buy
21
+6
+40% +$1.07K ﹤0.01% 909
2021
Q1 		$2K Buy
+15
New +$2.17K ﹤0.01% 1254

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Versant Capital Management's MRNA Position: Q2 2026 in Review

Versant Capital Management increased its Moderna (MRNA) stake by 86% in Q2 2026, buying an estimated $52.4K and bringing the position to 2,189 shares worth $153K. The position accounts for 0.01% of the portfolio, ranked #740.

Versant Capital Management first reported a position in MRNA in Q1 2021 and has held it in 22 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Versant Capital Management held 2,189 shares of Moderna worth $153K as of Q2 2026.
  • Versant Capital Management bought 1,013 Moderna shares in Q2 2026, an estimated $52.4K.
  • Moderna made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #740 holding.
  • Versant Capital Management first reported a position in Moderna in Q1 2021 and has held it in 22 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.